Ten-year surgical experiences with penile cancer at a tertiary care hospital in northwestern Tanzania: a retrospective study of 236 patients

World Journal of Surgical Oncology

Samson Simbila³  Nestory Masalu¹  Peter F Rambau⁴  Phillipo L Chalya² 

[1] Department of Oncology, Bugando Medical Centre, Mwanza, Tanzania;Department of Surgery, Bugando Medical Centre, Mwanza, Tanzania;Department of Urology, Bugando Medical Centre, Mwanza, Tanzania;Department of Pathology, Catholic University of Health and Allied Science-Bugando, Mwanza, Tanzania

关键词: Tanzania;    Treatment outcome;    Clinicopathological;    Penile cancer;   

Others  :  1130995
DOI  :  10.1186/s12957-015-0482-0

 received in 2014-11-01, accepted in 2015-01-22,  发布年份 2015

【 摘 要 】

Background

Penile cancer is an uncommon malignancy in developed countries, but the incidence is as high as 10% to 20% of all male cancers in some developing countries. There is a paucity of published data on this subject in our setting. This study describes the clinicopathological presentation and treatment outcome of this condition in our environment, and highlights challenges associated with the care of these patients and proffers solutions for improved outcome.

Methods

This was a retrospective study of histologically confirmed cases of penile cancer seen at Bugando Medical Centre between January 2004 and December 2013.

Results

There were 236 penile cancer patients representing 2.2% of all male malignancies during the study period. The median age was 47 years with a modal age group of 41 to 50 years. Of the 236 patients, 147 (62.3%) had severe phimosis. The majority of patients (89.8%) were uncircumcised. A history of human papilloma virus (HPV) was reported in 12 (5.1%) cases. One hundred eighty-two (77.1%) patients reported history of cigarette smoking. Seven (6.7%) patients were human immunodeficiency virus (HIV) positive. The majority of the patients (68.6%) presented with Jackson’s stages III and IV. Squamous cell carcinoma was the most common histopathological type (99.2%). Lymph node metastasis was recorded in 65.3% of cases, and it was significantly associated with the tumor size, histopathological subtype, histopathological grade, lympho-vascular invasion, positive resection margins, and urethral involvement (P < 0.001). Distant metastasis accounted for 4.2% of cases. The majority of patients (63.1%) underwent partial penectomy. Chemotherapy and radiotherapy were given in 14 (5.9%) and 12 (5.1%) patients, respectively. Complication and mortality rates were 22.0% and 4.2%, respectively. HIV positivity, histopathological stage and grade of the tumor, and presence of metastases at the time of diagnosis were the main predictors of death (P < 0.001). The median length of hospitalization was 14 days. Local recurrence was reported in 12 (5.3%) patients. Data on long-term survivals were not available as the majority of patients were lost to follow-up.

Conclusions

Penile cancer is not rare in our environment. The majority of patients present late with advanced stage of the disease. Early detection of primary cancer at an early stage may improve the prognosis.

【 授权许可】

   
2015 Chalya et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Barnholtz-Sloan JS, Maldonado J, Pow-Sang J, Giuliano AR: Incidence trends in primary malignant penile cancer. Urol Oncol 2007, 25:361-7.
• [2]Bleeker MCG, Heideman DAM, Snijders PJF, Horenblas S, Dillner J, Meijer C: Penile cancer: epidemiology, pathogenesis and prevention. World J Urol 2008, 27:141-50.
• [3]Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WGV, et al.: Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 2001, 159:1211-8.
• [4]Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S: Trends in cancer incidence in Kyadondo County, Uganda, 1960–1997. Brit J Cancer 2000, 82:1585-92.
• [5]Silva RS, Silva AC, Nascimento SG, Oliveira CM, Bonfim CV: Demographic and epidemiological aspects of mortality from penile cancer. Acta Paul Enferm 2014, 27:44-7.
• [6]Maden C, Sherman KJ, Beckmann AM: History of circumcisions, medical conditions, sexual activity and risk of penile cancer. J Nat Cancer Inst 1993, 16:1255-7.
• [7]Schoen EJ, Oehrli M, Colby C, Machin G: The highly protective effect of newborn circumcision against invasive penile cancer. Pediatrics 2000, 105:E36.
• [8]Tsen HF, Morgenstern H, Mack T, Peters RK: Risk factors for penile cancer: results of a population-based case–control study in Los Angeles County (United States). Cancer Causes Control 2001, 12:267-77.
• [9]Favorito LA, Nardi AC, Ronalsa M, Zequi SC, Sampaio FJB, Glina S: Epidemiologic study on penile cancer in Brazil. Int Braz J Urol 2008, 34:587-93.
• [10]Kyalwazi SK: Carcinoma of the penis: a review of 153 patients admitted to Mulago Hospital, Kampala, Uganda. East Afr Med J 1966, 43:415-25.
• [11]And BD, Kyalwazi SK: Review of carcinoma of penis at Mulago. East Afr Med J 1972, 49:996-1001.
• [12]Williams EH: A local cancer registry in a mission hospital in Uganda. East Afr Med J 1966, 43:200-7.
• [13]Elshleman JL: A study of the relative incidence of malignant tumors seen at Shirati Hospital in Tanzania. East Afr Med J 1966, 43:273-83.
• [14]Magoha GAO, Kaale RH: Epidemiological and clinical aspects of carcinoma of penis at Kenyatta National Hospital. East Afr Med J 1995, 72:359-61.
• [15]Magoha GAO, Ngumi ZWW: Cancer of the penis at Kenyatta National Hospital. East Afr Med J 2000, 77:526-30.
• [16]Reis AA, Paula LB, Paula AA, Saddi VA, Cruz AD: Aspectos clinicoepidemiologicos associados ao cancer de penis. Cienc Saude Coletiva 2010, 15:1105-11.
• [17]Pow-Sang MR, Ferreira U, Pow-Sang JM, Nardi AC, Destefano V: Epidemiology and natural history of penile cancer. Urology 2010, 76:S2-6.
• [18]Ficarra V, Akduman B, Bouchot O, Palou J, Tobias-Machado M: Prognostic factors in penile cancer. Urology 2010, 76:S66-73.
• [19]Jackson SM: The treatment of carcinoma of the penis. Br J Surg 1966, 53:33-5.
• [20]Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al.: Penile cancer: importance of circumcision, human papilloma virus and smoking in in situ and invasive disease. Int J Cancer 2005, 116:606-16.
• [21]Villa LL, Lopes A: Human papilloma virus DNA sequences in penile carcinomas in Brazil. Int J Cancer 1986, 37:853-5.
• [22]Werness BA, Levine AJ, Howley PM: Association of human papilloma virus types 16, and 18 E6 proteins with p53. Science 1990, 248:76-9.
• [23]Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR: Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006, 194:1044-57.
• [24]Hellberg D, Valentin J, Eklund T, Nilsson S: Penile cancer: is there an epidemiological role for smoking and sexual behaviour? Br Med J 1987, 295:1306-8.
• [25]Harish K, Ravi R: The role of tobacco in penile carcinoma. Br J Urol 1995, 75:375-7.
• [26]Sabin SR, Goldstein G, Rosenthal HG, Haynes KK: Aggressive squamous cell carcinoma originating as a Marjolin’s ulcer. Dermatol Surg 2004, 30:229-30.
• [27]Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, et al.: Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS 2006, 20:1645.
• [28]Poblet E, Alfaro L, Fernander-Segoviano P: Human papilloma virus-associated penile squamous cell carcinoma in HIV-positive patients. Am J Surg Pathol 1999, 23:1119-23.
• [29]Parkin DM, Wabinga H, Nambooze S, Wabwire-Mangen F: AIDS-related cancers in Africa: maturation of the epidemic in Uganda. AIDS 1999, 13:2563-70.
• [30]Graafland NM, Lam W, Leijte JA, Yap T, Gallee MP, Corbishley C, et al.: Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients. Eur Urol 2010, 58:742.
• [31]Arya M, Kalsi J, Kelly J, Muneer A: Malignant and premalignant lesions of the penis. BMJ 2013, 6(346):f1149. doi:10.1136/bmj.f1149
• [32]Ornellas AA, Kinchin EW, Nóbrega BL, Wisnescky A, Koifman N, Quirino R: Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience. J Surg Oncol 2008, 97:487.
• [33]Madej G, Douchez J, Combs PF: Cryosurgery of penile carcinoma: short report of preliminary results. Oncology 1982, 39:350-2.
• [34]Mohs FE, Snow N, Larson PO: Mohs micrographic surgery. Urol Clin North Am 1992, 19:291-304.
• [35]Ajekigbe AT, Anunobi CC, Tijani KH, Banjo AA, Nweke IG: Carcinoma of the penis: experience from the Lagos University Teaching Hospital Lagos, Nigeria. Nig Q J Hosp Med 2011, 21:25-8.
• [36]Minhas S, Manseck A, Watya S, Hegarty PK: Penile cancer—prevention and premalignant conditions. Urology 2010, 76:S24-35.